Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5032972 | 0.99 | EDNRB (0.98) | EDNRBEDNRA | |
| SCHEMBL8804417 | 0.92 | EDNRB (0.86) | EDNRBEDNRA | |
| SCHEMBL795650 | 0.91 | EDNRB (1.00) | EDNRBEDNRA | |
| SCHEMBL7206507 | 0.89 | EDNRB (0.83) | EDNRBEDNRA | |
| SCHEMBL8802029 | 0.89 | EDNRB (0.84) | EDNRBEDNRA | |
| SCHEMBL8659586 | 0.89 | EDNRA (0.85) | EDNRBEDNRA | |
| SCHEMBL8660578 | 0.87 | EDNRB (0.90) | EDNRBEDNRA | |
| SCHEMBL8659093 | 0.85 | EDNRB (0.81) | EDNRBEDNRA | |
| SCHEMBL8801607 | 0.84 | EDNRB (0.84) | EDNRBEDNRA | |
| SCHEMBL8662305 | 0.84 | EDNRB (0.84) | EDNRBEDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6395741-B1 | SENSITIVITY TO ENDOTHELIN; UROGENITAL DISORDERS | TANABE SEIYAKU CO., LTD. (JP) | 2002-05-28 | — | — | US | claimed |
| EP-1066831-A1 | PREVENTIVES/REMEDIES FOR URINARY DISORDER | TANABE SEIYAKU CO., LTD. (JP) | 2001-01-10 | — | — | EP | claimed |
| EP-0658548-B1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO (JP) | 1997-11-19 | — | — | EP | claimed |
| US-5589478-A | ENDOTHELIN ANTAGONISTS | TANABE SEIYAKU CO., LTD. (JP) | 1996-12-31 | — | — | US | claimed |
| JP-11343239-A | — | — | None | — | — | JP | disclosed |
| EP-2604256-B1 | Multi layer coatings | HEXAL AG (DE) | 2016-04-13 | — | — | EP | disclosed |
| EP-2604256-A1 | Multi layer coatings | Hexal AG (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-20120082721-A1 | Enteric coating | H E X A L AKTIENGESELLSCHAFT (DE) | 2012-04-05 | — | — | US | disclosed |
| EP-2255794-A1 | Enteric coating | H e x a l Aktiengesellschaft (DE) | 2010-12-01 | — | — | EP | disclosed |
| US-6610518-B2 | Using Cytochrome p450 | PFIZER INC. | 2003-08-26 | — | — | US | disclosed |
| US-6395741-B1 | SENSITIVITY TO ENDOTHELIN; UROGENITAL DISORDERS | TANABE SEIYAKU CO., LTD. (JP) | 2002-05-28 | — | — | US | disclosed |
| US-20020012977-A1 | Enzymatic oxidations | PFIZER PRODUCTS INC. | 2002-01-31 | — | — | US | disclosed |
| EP-1160331-A1 | Enzymatic oxidations | Pfizer Limited (GB) | 2001-12-05 | — | — | EP | disclosed |
| EP-1066831-A1 | PREVENTIVES/REMEDIES FOR URINARY DISORDER | TANABE SEIYAKU CO., LTD. (JP) | 2001-01-10 | — | — | EP | disclosed |
| JP-H11343239-A | PREVENTING AND THERAPEUTIC AGENT FOR DYSURIA | TANABE SEIYAKU CO LTD | 1999-12-14 | — | — | JP | disclosed |